Osteonecrosis of the jaw in a patient receiving bisphosphonate therapy.
Reilly
Margaret M
MM
New York University Clinical Cancer Center, New York, NY, USA. margaret.reilly@med.nyu.edu
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D004164:Diphosphonates / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D008334:Mandible; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates